Výsledky vyhledávání - "NAXIVA Trial Group"

A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA)

Autor: Stewart, Grant D, Welsh, Sarah J, Ursprung, Stephan, Gallagher, Ferdia A, Jones, James O, Shields, Jacqui, Smith, Christopher G, Mitchell, Thomas J, Warren, Anne Y, Bex, Axel, Boleti, Ekaterini, Carruthers, Jade, Eisen, Tim, Fife, Kate, Hamid, Abdel, Laird, Alexander, Leung, Steve, Malik, Jahangeer, Mendichovszky, Iosif A, Mumtaz, Faiz, Oades, Grenville, Priest, Andrew N, Riddick, Antony CP, Venugopal, Balaji, Welsh, Michelle, Riddle, Kathleen, Hopcroft, Lisa EM, NAXIVA Trial Group, Jones, Robert J

BACKGROUND: Surgery for renal cell carcinoma (RCC) with venous tumour thrombus (VTT) extension into the renal vein (RV) and/or inferior vena cava (IVC) has high peri-surgical morbidity/mortality. NAXIVA assessed the response of VTT to axitinib, a pot

Vyhledávací nástroje:

Upřesnit hledání